Barclays PLC Acquires 14,647 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Barclays PLC raised its holdings in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 111.9% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,737 shares of the company’s stock after purchasing an additional 14,647 shares during the period. Barclays PLC owned 0.15% of USANA Health Sciences worth $1,052,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Pzena Investment Management LLC grew its holdings in shares of USANA Health Sciences by 24.4% during the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock worth $44,183,000 after acquiring an additional 191,289 shares during the period. Pacer Advisors Inc. grew its holdings in shares of USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after acquiring an additional 76,904 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in shares of USANA Health Sciences by 14,068.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after acquiring an additional 38,547 shares during the period. Deerfield Management Company L.P. Series C grew its holdings in shares of USANA Health Sciences by 297.0% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock worth $1,346,000 after acquiring an additional 22,251 shares during the period. Finally, WINTON GROUP Ltd purchased a new stake in shares of USANA Health Sciences in the 2nd quarter worth approximately $890,000. Institutional investors own 54.25% of the company’s stock.

Insider Activity at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of the business’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.33% of the stock is owned by company insiders.

USANA Health Sciences Price Performance

NYSE USNA opened at $35.29 on Tuesday. The business’s fifty day moving average price is $37.88 and its 200-day moving average price is $39.84. The stock has a market capitalization of $672.63 million, a price-to-earnings ratio of 12.47, a PEG ratio of 1.25 and a beta of 0.89. USANA Health Sciences, Inc. has a 1-year low of $31.44 and a 1-year high of $54.81.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.07. The firm had revenue of $200.22 million for the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. During the same period in the prior year, the firm earned $0.59 EPS. Equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Analysts Set New Price Targets

Several analysts recently weighed in on USNA shares. DA Davidson upgraded USANA Health Sciences to a “hold” rating in a research note on Friday, December 20th. StockNews.com upgraded USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Saturday.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.